The BioPharma industry is facing a multitude of challenging external trends, from the growth in personalized medicine to supply chain disruptions and more.
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
A digital data backbone is key to a successful instrument data integration, speeding processes so that companies can get their therapies to market faster.
Accelerating tech transfer is vital with new precision medicine and increasing regulatory scrutiny of product quality and management of external partners.
Maintaining the balance between compliance and efficiency is what will set a CRO apart in the highly competitive outsourcing landscape and inspire the sponsor’s confidence.
Drug sponsors value – and rely on – the work that CROs perform. CROs have a chance to up their data management game. How can they ensure data quality?
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.
Now that we know what a microservice is and why it’s important, let’s explore deploying and managing cloud microservices in GxP environments.
What is a microservice? Let’s explore the term’s meaning, the benefits and how it can help boost your data security.
BioProcess International took place in Vienna this year, with talks centred around six main streams including cell line development and engineering, cell culture, recovery and purification, viral safety, cell and gene therapy as well as smaller sessions for manufacturing strategy and Industry 4.0 and vaccine manufacturing.